Altretamine (also hexalen) is an antineoplastic agent. It was approved by the FDA in 1990. ==Uses== It is used to treat refractory ovarian cancer. It is not considered a first-line treatment, but it can be useful as salvage therapy. It also has the advantage of being less toxic than other drugs used for treating refractory ovarian cancer. ==Mechan...
Found on
http://en.wikipedia.org/wiki/Altretamine
An anticancer drug that belongs to the family of drugs called alkylating agents.
Found on
http://www.cancer.gov/dictionary?expand=A
<chemical> N,n,n',n',n'',n''-hexamethyl-1,3,5-triazine-2,4,6-triamine. An alkylating agent proposed as an antineoplastic. It also acts as a chemosterilant for male houseflies and other insects. ... Pharmacological action: alkylating agents, antineoplastic agent, alkylating, chemosterilants. ... Chemical name: 1,3,5-Triazine-2,4,6-triamine, N,...
Found on
http://www.encyclo.co.uk/local/20973
(al-tret´ә-mēn) an antineoplastic agent used in the palliative treatment of ovarian carcinoma. It is structurally related to an alkylating agent but does not act as one; its exact mechanism is unknown. Administered orally.
Found on
http://www.encyclo.co.uk/local/21001
Our Altretamine Main Article provides a comprehensive look at the who, what, when and how of Altretamine Altretamine: Brand name: Hexalen. An oral drug used to treat ovarian cancer that has persisted or has recurred following treatment with other anti-cancer drugs. It was approved for this use by the FDA in 1990. Altretamine also has been used for ...
Found on
http://www.medterms.com/script/main/art.asp?articlekey=25757
No exact match found.
